Dianthus Therapeutics Inc (DNTH)

12:08 PM

Will Dianthus Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Short Interest & High Yield Stock Recommendations - Trung tâm Dự báo KTTV quốc gia

12:08 PM

04:26 AM

Is Dianthus Therapeutics Inc. (87E) stock at risk of policy regulationAnalyst Upgrade & Capital Efficient Trading Techniques - newser.com

04:26 AM

Oct 16, 2025

Evaluating Dianthus Therapeutics (DNTH) Valuation After New DNTH212 Licensing Deal and Pipeline Expansion - Yahoo Finance

Oct 16, 2025

Oct 16, 2025

Dianthus Therapeutics stock rating reiterated by TD Cowen after license deal - Investing.com Canada

Oct 16, 2025

Oct 16, 2025

Dianthus Therapeutics Strikes Deal For New Autoimmune Drug Rights - Finimize

Oct 16, 2025

Oct 16, 2025

Dianthus to license autoimmune disease candidate in a deal worth up to $1B (DNTH:NASDAQ) - Seeking Alpha

Oct 16, 2025

Oct 16, 2025

Leads Biolabs joins a $1B development deal with Dianthus - BioWorld MedTech

Oct 16, 2025

Oct 16, 2025

Dianthus Therapeutics Enters Into Exclusive DNTH212 Licensing Deal With Nanjing Leads Biolabs - Nasdaq

Oct 16, 2025

Oct 16, 2025

Dianthus Enters License Agreement for Autoimmune Drug; Shares Rise - MarketScreener

Oct 16, 2025

Oct 16, 2025

Dianthus Therapeutics Initiates Licensing Agreement for DNTH212, a Promising Treatment for Autoimmune Diseases with Unique Mechanism of Action - Quiver Quantitative

Oct 16, 2025

Oct 16, 2025

Dianthus Therapeutics Announces Exclusive License Agreement with Leads Biolabs for DNTH212, a ... - Bluefield Daily Telegraph

Oct 16, 2025

Oct 16, 2025

Dianthus Therapeutics Announces Exclusive License Agreement with Leads Biolabs for DNTH212, a First and Potentially Best-In-Class, Phase 1 Ready Bifunctional BDCA2 & BAFF/APRIL Inhibitor for Severe Autoimmune Diseases - Stock Titan

Oct 16, 2025

Oct 15, 2025

What candlestick patterns are forming on Dianthus Therapeutics Inc.Dip Buying & Daily Market Momentum Tracking - newser.com

Oct 15, 2025

Oct 15, 2025

Why retail investors pile into Dianthus Therapeutics Inc. stockJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - newser.com

Oct 15, 2025

Oct 14, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Earns Buy Rating from Analysts at Truist Financial - MarketBeat

Oct 14, 2025

Oct 14, 2025

Truist Securities initiates coverage on Dianthus Therapeutics stock with Buy rating - Investing.com

Oct 14, 2025

Oct 14, 2025

Can Dianthus Therapeutics Inc. stock hit analyst price targetsWeekly Investment Recap & Consistent Return Investment Signals - newser.com

Oct 14, 2025

Oct 13, 2025

Published on: 2025-10-13 08:04:31 - newser.com

Oct 13, 2025

Oct 13, 2025

Published on: 2025-10-13 07:23:46 - newser.com

Oct 13, 2025

Oct 10, 2025

What analysts say about Dianthus Therapeutics Inc stockStock Split Announcements & Free Navigate Market With Precision - earlytimes.in

Oct 10, 2025

Oct 10, 2025

When is the best time to exit Dianthus Therapeutics Inc.Earnings Trend Report & Weekly High Conviction Ideas - newser.com

Oct 10, 2025

Oct 10, 2025

How Dianthus Therapeutics Inc. stock benefits from global expansionTreasury Yields & Real-Time Stock Entry Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Dianthus Therapeutics (NASDAQ:DNTH) - MarketBeat

Oct 10, 2025

Oct 09, 2025

Is Dianthus Therapeutics Inc. (87E) stock a buy before new product rolloutQuarterly Growth Report & Fast Entry Momentum Trade Alerts - newser.com

Oct 09, 2025

Oct 07, 2025

Dianthus Therapeutics Experiences Revision in Its Stock Evaluation Amid Mixed Performance Indicators - Markets Mojo

Oct 07, 2025

Oct 06, 2025

Volume spikes in Dianthus Therapeutics Inc. stock – what they meanMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 06, 2025

Oct 06, 2025

Will Dianthus Therapeutics Inc. continue its uptrendInsider Buying & AI Enhanced Trading Signals - newser.com

Oct 06, 2025

Oct 06, 2025

Why Dianthus Therapeutics Inc. is moving todayTrade Risk Report & Free Long-Term Investment Growth Plans - newser.com

Oct 06, 2025

Oct 05, 2025

How Does Pritish Nandy Communications Ltd Compare to SP500 Over the Last 3 YearsFibonacci Extensions & Weekly Consultation With Financial Pros - earlytimes.in

Oct 05, 2025

Oct 05, 2025

What drives Dianthus Therapeutics Inc 87E stock priceDividend Growth Stocks & Free Expert Guidance For Growth - earlytimes.in

Oct 05, 2025

Oct 05, 2025

Advanced analytics toolkit walkthrough for Dianthus Therapeutics Inc.Market Sentiment Review & Safe Swing Trade Setup Alerts - newser.com

Oct 05, 2025

Oct 03, 2025

What Wall Street predicts for Dianthus Therapeutics Inc. stock priceQuarterly Earnings Report & Safe Capital Growth Tips - newser.com

Oct 03, 2025

Oct 03, 2025

What technical models suggest about Dianthus Therapeutics Inc.’s comebackJuly 2025 Rallies & Comprehensive Market Scan Reports - newser.com

Oct 03, 2025

Oct 02, 2025

Can Dianthus Therapeutics Inc. stock resist sector downturnsSell Signal & High Return Trade Opportunity Guides - newser.com

Oct 02, 2025

Oct 02, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 4.9%What's Next? - MarketBeat

Oct 02, 2025

Oct 02, 2025

Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2025 AANEM Annual Meeting - The Manila Times

Oct 02, 2025

Oct 02, 2025

Phase 2 Myasthenia Gravis Trial Results: Dianthus' Claseprubart Data to Be Unveiled at Major Conference - Stock Titan

Oct 02, 2025

Oct 01, 2025

Dianthus Therapeutics Hits New 52-Week High of $40.16 - Markets Mojo

Oct 01, 2025

Oct 01, 2025

What drives Okinawa Cellular Telephone Company OCU stock priceAnalyst Upgrades & High Profit Stock Alerts - earlytimes.in

Oct 01, 2025

Oct 01, 2025

Dianthus Therapeutics stock hits 52-week high at 40.0 USD By Investing.com - Investing.com Nigeria

Oct 01, 2025

Oct 01, 2025

Dianthus Therapeutics (DNTH) Hits New High as Drug Trial Sparks Optimism for Blockbuster Potential - MSN

Oct 01, 2025